Skip to main content
OpenTrials
Completed

NCT Number: NCT06229886

Effect of PEEP on TRJV in Mechanically Intubated Pediatric Patients

Prospective observational cohort study within the Pediatric Intensive Care Unit (PICU). We will perform point-of-care-ultrasound (POCUS) to quantify tricuspid regurgitant jet velocity (TRJV) on mechanically ventilated (MV) children. Mechanically ventilated (MV) children approaching extubation as per the discretion of the PICU clinical team will undergo a positive end expiratory pressure (PEEP) titration protocol in a safe and timely manner in the PICU. During this PEEP titration, POCUS will be performed by a pediatric intensivist and interpreted by a pediatric cardiologist. Medical demographics will be collected from the electronic medical record and recorded.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 month–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cohen Children's Medical Center

New Hyde Park, New York, 11040, United States

About this study

New admissions to the PICU will be identified by screening the electronic medical record (EMR) and all intubated patients will be screened and approached for enrollment if they meet inclusion criteria. After informed consent is obtained, subjects will be assigned a unique identifying number. Data will be stored in REDCap. A master link connecting subject POCUS image will be locked in the PI's office.

  • POCUS measurements: POCUS will be performed when a patient is determined to meet extubation readiness criteria as decided by the PICU clinical team. When the patient is on extubation readiness trial (ERT) settings (PEEP baseline), POCUS will be performed to assess TRJV. The PEEP will be increased to PEEP baseline+3 for 15 minutes followed by a repeat POCUS to assess TRJV. The PEEP will then be increased to PEEP baseline+5 (for a max total PEEP of 10mmHg) for 15 minutes followed by a repeat POCUS to assess TRJV. The patients will then be returned to baseline ERT (PEEP baseline) settings prior to the initial POCUS.
  • Interrater reliability will be evaluated amongst trained ultrasound providers by means of performing double scans for 25% of all scans performed. Each subject included in the study will have 3 scans in total (scan at PEEP baseline, scan at PEEP baseline+3, scan at PEEP baseline+5). Since the total number of scans in this study is 90, the number of double scans performed for interrater reliability will be about 22. Each double scan will include an expert ultrasound provider, along with novice ultrasound providers, who will be collecting data for this study. The novice ultrasound provider will participate in a brief informational session of how to obtain and interpret images with the expert provider.
  • Images will be stored in QPATH (our secure ultrasound-image database) and will not have any patient identifiers included. In addition, the attending of record will be contacted to determine if there are any extenuating medical or social circumstances that they believe should preclude the research team from performing the POCUS. If there are, the research team will forgo the POCUS.
  • The POCUS will then be reviewed by a board certified cardiologist and measurements of the TRJV will be obtained. The cardiologist will be blinded to the patient.
  • Information will be obtained from the EMR as outlined in our data collection sheet.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted to Cohen Children's Medical Center (CCMC) PICU who are age 3 months - 18 years old who are invasively mechanically ventilated (oral or nasotracheally).
  • Patients on or approaching extubation readiness trial.
  • Patients with structurally normal heart.
  • Patients with normally functioning heart.
  • Consent by a legal guardian.

Exclusion criteria

  • Patients with known air-leak syndrome.
  • Patients with history of congenital heart disease (CHD) (pre/post repair).
  • Patients with significant cardiac dysfunction and/or on vasoactive medications.
  • Patients with history of cardiomyopathy.
  • Patients with history of pulmonary hypertension.
  • Patients with history of chronic respiratory failure.
  • Patients with known mediastinal mass.
  • Patients with tracheostomy.

Treatment and study plan

Application of positive-end-expiratory pressure

Other

Application of PEEP on mechanically ventilated pediatric patients. Point-of-care-ultrasound performed after each PEEP application.

Primary outcomes

  1. Tricuspid Regurgitant Jet Velocity

    Time frame: 30 minutes

    The primary endpoint for the study will be TRJV at baseline PEEP (PEEP baseline) and subsequent PEEP increments (PEEP baseline+3, PEEP baseline+5).

Secondary outcomes

  1. Systolic Blood Pressure

    Time frame: 30 minutes

    mmHg

  2. Diastolic Blood Pressure

    Time frame: 30 minutes

    mmHg

  3. Mean Arterial Pressure

    Time frame: 30 Minutes

    mmHg

  4. Heart Rate

    Time frame: 30 minutes

    BPM (beats per minute)

Sponsors and collaborators

Lead sponsor

Northwell Health

Other

Registry information

Official study title

Effect of Positive End-Expiratory Pressure on Tricuspid Regurgitant Jet Velocity in Pediatric Patients on Invasive Mechanical Ventilation

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jan 29, 2024
Registry last updated
Sep 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.